Clinical trials recruiting in Villefranche-sur-Saône, France

Phase breakdown

Conditions recruiting in Villefranche-sur-Saône, France

Recruiting trials in Villefranche-sur-Saône, France

• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
  NCT05920356 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
  NCT06976203 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female)
• Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
  NCT05122806 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
  NCT06435468 · Phase: Not applicable (e.g. observational or device study) · Ages: 1 Year and older · Sex: All (male and female)
• FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
  NCT06393816 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
  NCT06837454 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
  NCT02511288 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
  NCT07243132 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
  NCT06646471 · Phase: Phase 4 · Ages: 70 Years and older · Sex: All (male and female)
• Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
  NCT06552234 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
  NCT07124858 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
  NCT06170788 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
  NCT06937905 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
  NCT07234058 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
  NCT06620835 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Villefranche-sur-Saône, France?

16 recruiting trials have at least one study site in Villefranche-sur-Saône, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.